Adam Scott Levy Net Worth
Track Major Insider Updates On X/TwitterLast Updated: 18 hours ago
Adam Scott Levy has an estimated net worth of at least $10.4 million*, as of yesterday. They own 48,538 shares of MLYS stock. They have sold 365,319 shares of MLYS stock since 2021, for an estimated $9.1 million.
Adam Scott Levy $MLYS SEC Form 4 Insider Trading
Adam Scott Levy has filed a total of 24 insider trades in $MLYS since 2021. Their most recent trade was a sale of 10,758 shares, made on Jan 12, 2026. Their largest trade was a sale of 96,815 shares, made on Jun 11, 2024. We estimate that they now own 48,538 shares of $MLYS, worth an estimated $1.4 million.
Insider Trading at $MLYS
There have been a total of 105 insider trades reported at $MLYS since 2021, with 7.8 million shares purchased and 3.1 million shares sold. The most active insider traders in $MLYS stock have been David Malcom Rodman, Jon Congleton, and Adam Scott Levy. The most recent trade was a sale of 2,171 shares reported by David Malcom Rodman (Chief Medical Officer), made on Mar 09, 2026.
History of Insider Stock Trades by Adam Scott Levy
| Company Ticker | Purchase / Sale | Shares | Date | Disclosed (EST) |
|---|---|---|---|---|
MLYS
|
Sale | 10,758 | Jan 12, 2026 | Jan. 13, 2026, 9:43 p.m. |
|
MLYS
|
Sale | 32,718 | Nov 11, 2025 | Nov. 13, 2025, 8:01 p.m. |
|
MLYS
|
Sale | 1,015 | Nov 11, 2025 | Nov. 13, 2025, 8:01 p.m. |
|
MLYS
|
Sale | 11,295 | Nov 11, 2025 | Nov. 13, 2025, 8:01 p.m. |
|
MLYS
|
Sale | 1,561 | Nov 11, 2025 | Nov. 13, 2025, 8:01 p.m. |
|
MLYS
|
Sale | 12,952 | Nov 11, 2025 | Nov. 13, 2025, 8:01 p.m. |
|
MLYS
|
Sale | 8,485 | Nov 11, 2025 | Nov. 13, 2025, 8:01 p.m. |
|
MLYS
|
Sale | 4,142 | Nov 11, 2025 | Nov. 13, 2025, 8:01 p.m. |
|
MLYS
|
Sale | 8,456 | Nov 11, 2025 | Nov. 13, 2025, 8:01 p.m. |
|
MLYS
|
Sale | 38,900 | Nov 11, 2025 | Nov. 13, 2025, 8:01 p.m. |
|
MLYS
|
Sale | 3,392 | Oct 13, 2025 | Oct. 15, 2025, 7:04 p.m. |
|
MLYS
|
Sale | 7,366 | Oct 13, 2025 | Oct. 15, 2025, 7:04 p.m. |
|
MLYS
|
Sale | 8,425 | Jul 30, 2025 | July 30, 2025, 8:12 p.m. |
|
MLYS
|
Sale | 12,946 | Jul 28, 2025 | July 30, 2025, 8:12 p.m. |
|
MLYS
|
Sale | 807 | Jul 29, 2025 | July 30, 2025, 8:12 p.m. |
|
MLYS
|
Sale | 51,500 | Jul 30, 2025 | July 30, 2025, 8:12 p.m. |
|
MLYS
|
Sale | 10,758 | Jul 11, 2025 | July 15, 2025, 5:01 p.m. |
|
MLYS
|
Sale | 10,757 | Apr 11, 2025 | April 15, 2025, 8:36 p.m. |
|
MLYS
|
Sale | 10,657 | Jan 13, 2025 | Jan. 15, 2025, 10:46 p.m. |
|
MLYS
|
Sale | 100 | Jan 13, 2025 | Jan. 15, 2025, 10:46 p.m. |
|
MLYS
|
Sale | 10,757 | Oct 11, 2024 | Oct. 15, 2024, 4:22 p.m. |
|
MLYS
|
Sale | 10,757 | Jul 11, 2024 | July 12, 2024, 4:37 p.m. |
|
MLYS
|
Sale | 96,815 | Jun 11, 2024 | June 13, 2024, 5:33 p.m. |
|
MLYS
|
Purchase | 6,250 | Feb 14, 2023 | Feb. 16, 2023, 5:54 p.m. |
$MLYS Executives and Stock Owners with Insider Trades
-
David Malcom Rodman, Chief Medical Officer
-
Jon Congleton, Chief Executive Officer
-
Adam Scott Levy, CFO and Secretary
-
Adam Scott Levy, CFO, Chief Bus. Off. and Secy.
*This is only based off of information found in SEC filings, and may not reflect actual net worth. There may also be inaccuracies due to privately holdings filing errors, parsing errors, accidental double-counting of shares, incorrect classification of indirectly owned shares, sales prior to dataset start date, or any other number of issues.